Renal Cell Carcinoma
📧 Sign up to get email alerts when something new happens for Renal Cell Carcinoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-04-03Clinical Trial Update: Volume 3D_US Kidney
Clinical trial update from Assistance Publique - Hôpitaux de Paris reporting completion of a study investigating kidney diseases, including …
-
CLINICAL_TRIALS research · 2026-04-03Clinical Trial Update: Testing Longer Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With Cancer That Has Spread to the Brain [Phase 3]
Phase 3 trial comparing longer-duration radiation therapy versus standard radiation therapy for patients with cancer that has spread to the …
-
CLINICAL_TRIALS research · 2026-04-03Clinical Trial Update: Neoadjuvant Zanzalintinib Plus Nivolumab in Patients With Locally Advanced and/or Inoperable Clear Cell Renal Cell Carcinoma With or Without Non-measurable Metastasis [Phase 2]
A Phase 2 neoadjuvant trial evaluating Zanzalintinib plus nivolumab for locally advanced or inoperable clear cell renal cell carcinoma (with…
-
CLINICAL_TRIALS trial_result · 2026-04-03Clinical Trial Update: 9-ING-41 in Patients With Advanced Cancers [Phase 2]
Actuate Therapeutics' Phase 2 trial of 9-ING-41 in patients with advanced cancers is currently active but not recruiting, with pancreatic ca…
-
CLINICAL_TRIALS research · 2026-04-03Clinical Trial Update: Cancer and Blood Pressure Management, CARISMA Study [NA]
An ECOG-ACRIN clinical trial update on the CARISMA study, investigating cancer care with blood pressure management in patients with cardiova…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2026-04-03Clinical Trial Update: Focused Radiation Versus Systemic Therapy for Kidney Cancer Patients With Limited Metastasis, SOAR Study [Phase 3]
A Phase 3 trial (SOAR) is evaluating focused radiation versus systemic therapy for kidney cancer with limited metastasis; the study is curre…
-
CLINICAL_TRIALS research · 2026-04-03Clinical Trial Update: Stereotactic Body Proton Therapy for Treatment of Primary Renal Cell Carcinoma [Phase 2]
Phase 2 clinical trial evaluating stereotactic body proton therapy for primary renal cell carcinoma is currently recruiting.
-
CLINICAL_TRIALS research · 2026-04-03Clinical Trial Update: Trial of Zanzalintinib (XL092) in Combination With Immunotherapy in Patients Who Progress on Adjuvant Therapy in Clear Cell RCC [Phase 2]
This is a Phase 2 clinical trial update for Zanzalintinib (XL092) in combination with immunotherapy for advanced or metastatic renal cell ca…
-
CLINICAL_TRIALS research · 2026-04-03Clinical Trial Update: VSV-IFNβ-NIS With Ipilimumab and Nivolumab for the Treatment of Advanced or Metastatic Clear Cell Renal Cell Carcinoma [Phase 2]
A Phase 2 trial evaluating VSV-IFNβ-NIS in combination with ipilimumab and nivolumab for advanced or metastatic clear cell renal cell carcin…
-
CLINICAL_TRIALS research · 2026-04-03Clinical Trial Update: A Randomized Trial of Fianlimab and Cemiplimab +/- Ipilimumab or Ipilimumab Plus Nivolumab in First-line Advanced Renal Cell Carcinoma (RCC) [Phase 2]
A Phase 2 randomized trial evaluating the combination of fianlimab and cemiplimab with or without ipilimumab, or ipilimumab plus nivolumab, …
-
CLINICAL_TRIALS research · 2026-04-02Clinical Trial Update: Myeloid Derived Suppressor Cells Clinical Assay in Finding Kidney Cancer
A USC-sponsored clinical trial evaluates a myeloid-derived suppressor cell assay in renal cell carcinoma; the study is active but not recrui…
-
CLINICAL_TRIALS trial_result · 2026-04-02Clinical Trial Update: A Phase 1, Dose-escalation Study of [225Ac]-FPI-2068 in Adult Patients With Advanced Solid Tumours [Phase 1]
Clinical trial update describes a Phase 1 dose-escalation study of [225Ac]-FPI-2068 in adults with advanced solid tumors, currently recruiti…
-
CLINICAL_TRIALS research · 2026-04-02Clinical Trial Update: A Phase 1b Study of HC-7366, an Agonist of ISR With Immunotherapy in Kidney Cancer (SHARK) [Phase 1]
A Phase 1b trial (SHARK) evaluating HC-7366, an ISR agonist, in kidney cancer is currently recruiting.
-
CLINICAL_TRIALS trial_result · 2026-04-01Clinical Trial Update: Study to Evaluate the Safety and Efficacy of Bicalutamide in Combination With Sunitinib in Patients With TKIs-resistant RCC [Phase 1, Phase 2]
A Phase 1/2 clinical trial is evaluating the safety and efficacy of combining bicalutamide with sunitinib in patients with renal cell carcin…
-
CLINICAL_TRIALS trial_result · 2026-04-01Clinical Trial Update: Gevokizumab With Standard of Care Anti-cancer Therapies for Metastatic Colorectal, Gastroesophageal, and Renal Cancers [Phase 1]
This Phase 1 trial evaluates gevokizumab in combination with standard-of-care anticancer therapies for metastatic colorectal cancer, gastroe…
-
CLINICAL_TRIALS research · 2026-04-01Clinical Trial Update: A Study of the Effectiveness of Cabozantinib in Combination With Nivolumab as First-line Treatment of Advanced Renal Cell Carcinoma (aRCC) in Adults
This clinical trial update describes a study evaluating the effectiveness of cabozantinib in combination with nivolumab as first-line treatm…
-
CLINICAL_TRIALS research · 2026-04-01Clinical Trial Update: Phase 3 Study to Assess Safety and Efficacy of 177Lu-TLX250 in Advanced Relapsed or Recurrent ccRCC [Phase 3]
Phase 3 study to assess safety and efficacy of 177Lu-TLX250 in advanced relapsed or recurrent clear cell renal cell carcinoma is currently r…
-
CLINICAL_TRIALS research · 2026-04-01Clinical Trial Update: Patient-partnered Research in Investigating Fear of Cancer Recurrence in Kidney Cancer
This ClinicalTrials.gov study is recruiting to explore patient-partnered research on Fear of Cancer Recurrence in individuals with Renal Cel…
-
CLINICAL_TRIALS research · 2026-03-31Clinical Trial Update: Observational Real-life Study of Cabozantinib in Monotherapy or in Combination With Nivolumab in Advanced Renal Cell Carcinoma (RCC)
An observational real-world study assessing cabozantinib as monotherapy or in combination with nivolumab for advanced or metastatic renal ce…
-
CLINICAL_TRIALS trial_result · 2026-03-31Clinical Trial Update: Therapeutic Drug Monitoring of Sunitinib and Pazopanib in Advanced or Metastatic Renal Cell Carcinoma [Phase 4]
This is a Phase 4 clinical trial update evaluating therapeutic drug monitoring of sunitinib and pazopanib in advanced or metastatic renal ce…
-
CLINICAL_TRIALS research · 2026-03-31Clinical Trial Update: A Study to Evaluate the Safety, Tolerability, and Efficacy of Pumitamig Alone or in Combination With Ipilimumab or Cabozantinib in Participants With Advanced Renal Cell Carcinoma (RCC) (ROSETTA RCC-208) [Phase 1, Phase 2]
A Phase 1/2 clinical trial is evaluating Pumitamig alone or in combination with ipilimumab or cabozantinib in adults with advanced renal cel…
-
CLINICAL_TRIALS research · 2026-03-31Clinical Trial Update: Study of AB598 Monotherapy and Combination Therapy in Participants With Advanced Cancers [Phase 1]
Phase 1 study of AB598 as monotherapy and in combination across multiple advanced cancers is ongoing, with status active but not recruiting.
-
CLINICAL_TRIALS research · 2026-03-31Clinical Trial Update: DESTINY-PANTUMOUR04
Clinical trial update for the DESTINY-PANTUMOUR04 study sponsored by AstraZeneca, evaluating trastuzumab deruxtecan across multiple cancer t…
-
CLINICAL_TRIALS research · 2026-03-31Clinical Trial Update: Von Hippel-Lindau (VHL): Clinical Manifestations, Diagnosis, Management and Molecular Bases of Inherited Renal and Other Urologic Malignant Disorders
An NCI-sponsored clinical trial evaluating Von Hippel-Lindau–associated renal and other urologic malignancies, including manifestations, dia…
-
CLINICAL_TRIALS research · 2026-03-30Clinical Trial Update: Fasting-Mimicking Diet Combined With IO-TKI Combination Therapy in Patients With Metastatic Renal Cell Carcinoma [NA]
Clinical trial update for a metastatic renal cell carcinoma study evaluating a fasting-mimicking diet in combination with IO-TKI therapy; th…